Protection by ultraviolet A and B sunscreens against in situ dipyrimidine photolesions in human epidermis is comparable to protection against sunburn.
Affiliation
Department of Environmental Dermatology, St. John's Institute of Dermatology, King's College London, St. Thomas's Hospital, London, UK. antony.r.young@kcl.ac.ukIssue Date
2000-07
Metadata
Show full item recordAbstract
Sunscreens prevent sunburn and may also prevent skin cancer by protecting from ultraviolet-induced DNA damage. We assessed the ability of two sunscreens, with different spectral profiles, to inhibit DNA photodamage in human epidermis in situ. One formulation contained the established ultraviolet B filter octyl methoxycinnamate, whereas the other contained terephthalylidene dicamphor sulfonic acid, a new ultraviolet A filter. Both formulations had sun protection factors of 4 when assessed with solar simulating radiation in volunteers of skin type I/II. We tested the hypothesis that sun protection factors would indicate the level of protection against DNA photodamage. Thus, we exposed sunscreen-treated sites to four times the minimal erythema dose of solar simulating radiation, whereas vehicle and control sites were exposed to one minimal erythema dose. We used monoclonal antibodies against thymine dimers and 6-4 photoproducts and image analysis to quantify DNA damage in skin sections. A dose of four times the minimal erythema dose, with either sunscreen, resulted in comparable levels of thymine dimers and 6-4 photoproducts to one minimal erythema dose +/- vehicle, providing evidence that the DNA protection factor is comparable to the sun protection factor. The lack of difference between the sunscreens indicates similar action spectra for erythema and DNA photodamage and that erythema is a clinical surrogate for DNA photodamage that may lead to skin cancer.Citation
Protection by ultraviolet A and B sunscreens against in situ dipyrimidine photolesions in human epidermis is comparable to protection against sunburn. 2000, 115 (1):37-41 J. Invest. Dermatol.Journal
The Journal of Investigative DermatologyDOI
10.1046/j.1523-1747.2000.00012.xPubMed ID
10886505Type
ArticleLanguage
enISSN
0022-202Xae974a485f413a2113503eed53cd6c53
10.1046/j.1523-1747.2000.00012.x
Scopus Count
Collections
Related articles
- Protection against pyrimidine dimers, p53, and 8-hydroxy-2'-deoxyguanosine expression in ultraviolet-irradiated human skin by sunscreens: difference between UVB + UVA and UVB alone sunscreens.
- Authors: Liardet S, Scaletta C, Panizzon R, Hohlfeld P, Laurent-Applegate L
- Issue date: 2001 Dec
- Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet a in the face of constant ultraviolet B protection.
- Authors: Poon TS, Barnetson RS, Halliday GM
- Issue date: 2003 Jul
- A commercial sunscreen's protection against ultraviolet radiation-induced immunosuppression is more than 50% lower than protection against sunburn in humans.
- Authors: Kelly DA, Seed PT, Young AR, Walker SL
- Issue date: 2003 Jan
- A broad spectrum high-SPF photostable sunscreen with a high UVA-PF can protect against cellular damage at high UV exposure doses.
- Authors: Cole C, Appa Y, Ou-Yang H
- Issue date: 2014 Aug
- Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results.
- Authors: Fourtanier A, Moyal D, Seité S
- Issue date: 2008 Aug